Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2299-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-5437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B15-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-30 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B15-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-54 |
filingDate |
2002-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ecc470806c30b876a5200d38c9ec581 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13ea98561832b01957111c063fb9cbdf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f661a7760e3a6a1f6f4088c703c16261 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c205683df0bf48e96e3e01a6c1b6693 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_175371dd9b65b7f838ab77233ae6bb96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7e05b4e8457c690f3a4b79e07754ecf |
publicationDate |
2004-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1402451-A1 |
titleOfInvention |
Solution structure of il-13 and uses thereof |
abstract |
The present invention relates to the three dimensional solution structure of interleukin-13 (IL-13), as well as the identification and characterization of various binding active sites of IL-13. Also provided for by the present invention are methods of utilizing the three dimensional structure for the design and selection of potent and selective agents that interact with IL-13. |
priorityDate |
2001-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |